Showing results (481-490 of 686) with videos related to

Sort By:
Pageof 69
Hepatology (Baltimore, Md.)|September 9, 2025
Natural history and development of a novel composite endpoint in patients with alcohol-associated hepatitis: Data from a prospective multicenter studySrinivasan Dasarathy, Wanzhu Tu, Nicole Welch, et al.
Hepatology International|August 21, 2021
A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosisCheng Han Ng, Darren Jun Hao Tan, Kameswara Rishi Yeshayahu Nistala, et al.
Scientific Reports|August 19, 2018
An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic SteatohepatitisYi Luo, Abdul Oseini, Robert Gagnon, et al.
Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care|March 24, 2018
Treatment of HCV in the Department of Corrections in the Era of Oral MedicationsRichard K Sterling, Reena Cherian, Shawn Lewis, et al.
Nature Medicine|June 7, 2026
Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trialLee M Kaplan, Elena Startseva, Carel W le Roux, et al.
Clinical and Molecular Hepatology|December 28, 2025
MicroRNA isomiRs reveal novel pathways linked to disease activity and fibrosis in MASLDChristian Brion, Stephen A Hoang, Guangliang Wang, et al.
Cell Reports|March 2, 2022
Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinomaFaridoddin Mirshahi, Hussein F Aqbi, Madison Isbell, et al.
Gastroenterology|February 25, 2010
Persistence of cognitive impairment after resolution of overt hepatic encephalopathyJasmohan S Bajaj, Christine M Schubert, Douglas M Heuman, et al.
The New England Journal of Medicine|June 10, 2024
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver FibrosisRohit Loomba, Mark L Hartman, Eric J Lawitz, et al.
Hepatology (Baltimore, Md.)|September 1, 2017
Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver diseaseRaj Vuppalanchi, Mohammad S Siddiqui, Mark L Van Natta, et al.
Pageof 69